MTOR and melanoma: Similarly, Schalper et al. demonstrated a strong negative correlation between high serum IL-8 and OS in a large cohort of patients from four clinical trials of advanced renal cell carcinoma, melanoma, and non-small cell lung cancer treated with ICI, chemotherapy, or mTOR inhibitors, regardless of the applied treatment [49].